Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 4/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.32 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12226204 | 0.98 | LMNA (0.50) | LMNAOPRM1DNM1TSHRFDPS | |
| SCHEMBL4609781 | 0.98 | LMNA (0.50) | LMNAOPRM1DNM1TSHRFDPS | |
| SCHEMBL8886404 | 0.95 | LMNA (0.50) | LMNAOPRM1ALDH1A1TDP1DNM1 | |
| SCHEMBL23327936 | 0.92 | LMNA (0.54) | LMNAOPRM1ALDH1A1DNM1TSHR | |
| SCHEMBL11078123 | 0.92 | LMNA (0.54) | LMNAOPRM1ALDH1A1DNM1TSHR | |
| SCHEMBL18256102 | 0.92 | ALDH1A1 (0.42) | LMNAALDH1A1TDP1DNM1TSHR | |
| SCHEMBL28990460 | 0.92 | LMNA (0.54) | LMNAOPRM1ALDH1A1DNM1TSHR | |
| SCHEMBL28990462 | 0.92 | LMNA (0.54) | LMNAOPRM1ALDH1A1DNM1TSHR | |
| SCHEMBL7754804 | 0.92 | LMNA (0.48) | LMNAOPRM1ALDH1A1TDP1DNM1 | |
| SCHEMBL11651348 | 0.88 | LMNA (0.50) | LMNAOPRM1ALDH1A1DNM1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105985774-B | The application of nanocrystalline-ligand complex, preparation method, printing material and printing material | 纳晶科技股份有限公司 | 2019-05-28 | — | — | CN | claimed |
| CN-105985774-A | Nanocrystalline-ligand compound, preparation method of nanocrystalline-ligand compound, printing material and use of printing material | 纳晶科技股份有限公司 | 2016-10-05 | — | — | CN | claimed |
| CN-105985774-B | The application of nanocrystalline-ligand complex, preparation method, printing material and printing material | 纳晶科技股份有限公司 | 2019-05-28 | — | — | CN | disclosed |
| CN-105985774-A | Nanocrystalline-ligand compound, preparation method of nanocrystalline-ligand compound, printing material and use of printing material | 纳晶科技股份有限公司 | 2016-10-05 | — | — | CN | disclosed |
| US-8288155-B2 | Biomolecular attachment sites on microelectronic arrays and methods thereof | GAMIDA FOR LIFE B.V. (NL) | 2012-10-16 | — | — | US | disclosed |
| US-20090069198-A1 | Biomolecular Attachment Sites on Microelectronic Arrays and Methods Thereof | ADOR DIAGNOSTICS S.R.L. (IT) | 2009-03-12 | — | — | US | disclosed |
| EP-1976505-A1 | COMBRETASTATIN DERIVATIVES AND RELATED THERAPEUTIC METHODS | Abraxis BioScience, Inc. (US) | 2008-10-08 | — | — | EP | disclosed |
| WO-2007059118-A1 | COMBRETASTATIN DERIVATIVES AND RELATED THERAPEUTIC METHODS | ABRAXIS BIOSCIENCE, INC. (US) | 2007-05-24 | — | — | WO | disclosed |
| US-5650430-A | Radicicol derivatives, their preparation and their anti-tumor activity | SANKYO COMPANY, LIMITED (JP) | 1997-07-22 | — | — | US | disclosed |
| US-5597846-A | ESTERS OF RADICICOL | SANKYO COMPANY, LIMITED (JP) | 1997-01-28 | — | — | US | disclosed |
| WO-1991018905-A1 | RADICICOL DERIVATIVES, THEIR PREPARATION AND THEIR ANTI-TUMOR ACTIVITY | SANKYO COMPANY LIMITED (JP) | 1991-12-12 | — | — | WO | disclosed |
| EP-0460950-A1 | Radicicol derivatives, their preparation and their anti-tumour activity | Sankyo Company Limited (JP) | 1991-12-11 | — | — | EP | disclosed |